Cargando…
The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
OBJECTIVE: To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024368/ https://www.ncbi.nlm.nih.gov/pubmed/21270200 http://dx.doi.org/10.2337/dc10-1734 |
_version_ | 1782196774066192384 |
---|---|
author | Singh, Premranjan P. Abbott, J. Dawn Lombardero, Manuel S. Sutton-Tyrrell, Kim Woodhead, Gail Venkitachalam, Lakshmi Tsapatsaris, Nicholas P. Piemonte, Thomas C. Lago, Rodrigo M. Rutter, Martin K. Nesto, Richard W. |
author_facet | Singh, Premranjan P. Abbott, J. Dawn Lombardero, Manuel S. Sutton-Tyrrell, Kim Woodhead, Gail Venkitachalam, Lakshmi Tsapatsaris, Nicholas P. Piemonte, Thomas C. Lago, Rodrigo M. Rutter, Martin K. Nesto, Richard W. |
author_sort | Singh, Premranjan P. |
collection | PubMed |
description | OBJECTIVE: To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classified as: normal, 0.91–1.3; low, ≤0.9; high, >1.3; or noncompressible artery (NC). Baseline characteristics were examined according to ABI and by multivariate analysis. RESULTS: ABI was normal in 66%, low in 19%, and high in 8% of patients, and 6% of patients had NC. Of the low ABI patients, 68% were asymptomatic. Using normal ABI as referent, low ABI was independently associated with smoking, female sex, black race, hypertension, age, C-reactive protein, diabetes duration, and lower BMI. High ABI was associated with male sex, nonblack race, and higher BMI; and NC artery was associated with diabetes duration, higher BMI, and hypertension. CONCLUSIONS: ABI abnormalities are common and often asymptomatic in patients with type 2 diabetes and CAD. |
format | Text |
id | pubmed-3024368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-30243682012-02-01 The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial Singh, Premranjan P. Abbott, J. Dawn Lombardero, Manuel S. Sutton-Tyrrell, Kim Woodhead, Gail Venkitachalam, Lakshmi Tsapatsaris, Nicholas P. Piemonte, Thomas C. Lago, Rodrigo M. Rutter, Martin K. Nesto, Richard W. Diabetes Care Original Research OBJECTIVE: To examine ankle-brachial index (ABI) abnormalities in patients with type 2 diabetes and coronary artery disease (CAD). RESEARCH DESIGN AND METHODS: An ABI was obtained in 2,240 patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. ABIs were classified as: normal, 0.91–1.3; low, ≤0.9; high, >1.3; or noncompressible artery (NC). Baseline characteristics were examined according to ABI and by multivariate analysis. RESULTS: ABI was normal in 66%, low in 19%, and high in 8% of patients, and 6% of patients had NC. Of the low ABI patients, 68% were asymptomatic. Using normal ABI as referent, low ABI was independently associated with smoking, female sex, black race, hypertension, age, C-reactive protein, diabetes duration, and lower BMI. High ABI was associated with male sex, nonblack race, and higher BMI; and NC artery was associated with diabetes duration, higher BMI, and hypertension. CONCLUSIONS: ABI abnormalities are common and often asymptomatic in patients with type 2 diabetes and CAD. American Diabetes Association 2011-02 2011-01-20 /pmc/articles/PMC3024368/ /pubmed/21270200 http://dx.doi.org/10.2337/dc10-1734 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Singh, Premranjan P. Abbott, J. Dawn Lombardero, Manuel S. Sutton-Tyrrell, Kim Woodhead, Gail Venkitachalam, Lakshmi Tsapatsaris, Nicholas P. Piemonte, Thomas C. Lago, Rodrigo M. Rutter, Martin K. Nesto, Richard W. The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial |
title | The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial |
title_full | The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial |
title_fullStr | The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial |
title_full_unstemmed | The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial |
title_short | The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial |
title_sort | prevalence and predictors of an abnormal ankle-brachial index in the bypass angioplasty revascularization investigation 2 diabetes (bari 2d) trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024368/ https://www.ncbi.nlm.nih.gov/pubmed/21270200 http://dx.doi.org/10.2337/dc10-1734 |
work_keys_str_mv | AT singhpremranjanp theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT abbottjdawn theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT lombarderomanuels theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT suttontyrrellkim theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT woodheadgail theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT venkitachalamlakshmi theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT tsapatsarisnicholasp theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT piemontethomasc theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT lagorodrigom theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT ruttermartink theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT nestorichardw theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT theprevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT singhpremranjanp prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT abbottjdawn prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT lombarderomanuels prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT suttontyrrellkim prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT woodheadgail prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT venkitachalamlakshmi prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT tsapatsarisnicholasp prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT piemontethomasc prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT lagorodrigom prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT ruttermartink prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT nestorichardw prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial AT prevalenceandpredictorsofanabnormalanklebrachialindexinthebypassangioplastyrevascularizationinvestigation2diabetesbari2dtrial |